A pilot study of quality of life of patients with hormone-refractory prostate cancer after gene therapy.
Terao S, Shirakawa T, Acharya B, Miyata M, Hinata N, Tanaka K, Takenaka A, Hara I, Naoe M, Fuji K, Okegawa T, Higashihara E, Kamidono S, Fujisawa M, Gotoh A.
Terao S, et al. Among authors: acharya b.
Anticancer Res. 2009 May;29(5):1533-7.
Anticancer Res. 2009.
PMID: 19443362
Free article.